How to Get Finasteride in Michigan

What Is Finasteride and Why Michigan Patients Use It

Finasteride is a 5-alpha-reductase type II inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH). It comes in two FDA-approved dose forms: 1 mg (brand name Propecia) for male pattern hair loss and 5 mg (brand name Proscar) for BPH. Generic versions from multiple manufacturers are available at virtually every Michigan pharmacy.

The drug's clinical record is well-established. In the landmark Kaufman et al. trial published in the Journal of the American Academy of Dermatology, finasteride 1 mg daily for 2 years produced a statistically significant increase in hair count compared to placebo (P<0.001) in men with vertex and anterior mid-scalp hair loss [1]. A companion 5-year open-label extension showed that 48% of men who continued treatment had increased hair count versus baseline, while men who stopped after 2 years lost the gains within 12 months [2].

For BPH, the Prostate Cancer Prevention Trial (PCPT, N=18,882) provided the longest-term safety and efficacy data, demonstrating finasteride reduced prostate volume by roughly 20% over 7 years [3]. The FDA's full prescribing information confirms both indications and the boxed warning regarding exposure in women of childbearing potential [4].

Michigan sees high demand for both indications. The state's population of approximately 10 million includes a large proportion of men over 40 for whom BPH or hair loss becomes clinically relevant, and the state's mature telehealth infrastructure makes access straightforward.

Michigan's Legal Framework for Prescribing Finasteride

Michigan law explicitly permits telehealth prescribing. Under MCL 333.16285, a Michigan-licensed prescriber may establish a valid patient-prescriber relationship via synchronous audio-visual telehealth, after which controlled and non-controlled prescription drugs may be issued without a prior in-person visit [5]. Finasteride is not a controlled substance, so no DEA-schedule restrictions apply.

Prescribers who may write finasteride in Michigan include:

• Physicians (MD/DO) licensed under the Michigan Public Health Code.
• Nurse Practitioners (NPs) operating under full practice authority. Michigan granted NPs full independent prescribing authority in 2017 under PA 169, meaning NPs do not require physician oversight to prescribe finasteride.
• Physician Assistants (PAs) who must maintain a collaboration agreement with a supervising physician. The PA's scope of practice document must include prescribing in dermatology or urology/primary care.

Prescribers practicing entirely outside Michigan cannot prescribe to Michigan-resident patients unless they hold a Michigan license or a recognized reciprocal credential. Patients should confirm the prescriber's Michigan licensure number before any telehealth consultation, which is verifiable through the Michigan Department of Licensing and Regulatory Affairs (LARA) online portal.

How to Get a Finasteride Prescription in Michigan: Step by Step

Getting finasteride in Michigan takes four steps. Most patients complete the process within 48 hours when using a telehealth platform.

Step 1. Choose your care pathway. Options include a primary care physician, a dermatologist (for AGA), a urologist (for BPH), or a telehealth platform licensed in Michigan. Telehealth platforms typically offer asynchronous questionnaire-based visits or synchronous video appointments. Synchronous visits are preferred when BPH symptoms are complex or when a PSA result needs clinical interpretation.

Step 2. Complete the clinical intake. The prescriber will review your symptom history, current medications (especially alpha-blockers, 5-ARIs already in use, or CYP3A4-affected drugs), and any relevant labs. Men over 40 or those with urinary symptoms should have a baseline PSA drawn before the first dose. The FDA label notes that finasteride decreases PSA by approximately 50% after 6 months of use, so an untreated baseline is needed to interpret future PSA values correctly [4].

Step 3. Receive and fill the prescription. The prescriber sends the prescription electronically to your preferred Michigan pharmacy. Michigan participates in the national e-prescribing network, so any licensed in-state or mail-order pharmacy can receive the order. Generic finasteride 1 mg (30-tablet supply) costs approximately $10 to $25 at GoodRx-negotiated rates at Meijer, Walmart, Kroger, and CVS locations throughout the state [6].

Step 4. Schedule follow-up. The American Academy of Dermatology (AAD) guideline recommends reassessing hair loss patients at 12 months to evaluate treatment response, since meaningful regrowth requires sustained DHT suppression over that window [7]. BPH patients typically return at 3 to 6 months for symptom score reassessment and a repeat PSA.

Telehealth Providers Prescribing Finasteride in Michigan

Several categories of telehealth providers serve Michigan residents. National platforms with Michigan-licensed prescribers include direct-to-consumer men's health services, general telehealth companies, and specialty hormone-therapy clinics such as HealthRX. State-specific requirements every Michigan telehealth prescriber must meet include: holding an active Michigan license, conducting a visit that meets the standard of care (not merely a checkbox intake), and maintaining medical records accessible to the patient under the Michigan Medical Records Access Act.

When evaluating a telehealth provider, ask four questions. Does the platform employ Michigan-licensed prescribers? Does the intake include a review of contraindications (hypersensitivity to finasteride or dutasteride, pregnancy exposure risk for female partners)? Does the provider order or review PSA results for men over 40? Does the platform offer follow-up messaging for side-effect management?

The HealthRX Michigan Finasteride Access Framework categorizes patients into three tiers based on intake complexity:

• Tier 1 (uncomplicated AGA, age 18 to 40, no BPH symptoms, no PSA concern): Asynchronous questionnaire visit is sufficient. Prescription issued same day.
• Tier 2 (AGA with mild lower urinary tract symptoms, or age 40 to 55 with PSA not yet drawn): Synchronous video visit required. Labs ordered concurrently; prescription held until PSA result reviewed.
• Tier 3 (known BPH, PSA above 4.0 ng/mL, prior prostate biopsy, or complex medication list): In-person urology evaluation recommended before finasteride initiation or continuation.

This tiered approach aligns with the Endocrine Society's principle that 5-ARI prescribing in men with elevated PSA warrants urological co-management [8].

What Labs Are Needed Before Starting Finasteride in Michigan?

Lab requirements depend on indication and age. No single universal panel is mandated by Michigan law, but clinical guidelines and the FDA label provide clear direction [4].

For AGA in men under 40 with no urinary symptoms, labs are optional. A scalp assessment and medical history are sufficient for most prescribers. Some clinicians add a serum testosterone and DHT to confirm androgen-pattern loss rather than a nutrient-deficiency-driven shed, though the AAD does not require this before prescribing [7].

For men over 40, or any man with lower urinary tract symptoms, a baseline PSA is standard of care. The National Comprehensive Cancer Network (NCCN) guideline on prostate cancer early detection states that finasteride use without a baseline PSA makes subsequent values uninterpretable for screening purposes [9]. Draw PSA before the first dose or within 30 days of starting if urgency requires earlier initiation.

Additional labs a Michigan clinician may order include:

• Liver function tests (LFTs): Finasteride is hepatically metabolized. Clinically significant hepatotoxicity is rare, but a baseline ALT/AST is reasonable in patients with known liver disease.
• Complete blood count (CBC): Not routinely required but occasionally ordered when diffuse hair loss raises concern for iron deficiency anemia or thyroid disease as alternate diagnoses.
• TSH and serum ferritin: Recommended when AGA diagnosis is uncertain, per AAD guidelines, to exclude thyroid dysfunction and iron deficiency before attributing hair loss to androgens [7].

Results can be drawn at any Michigan LabCorp, Quest Diagnostics, or hospital outpatient lab. Many telehealth platforms integrate lab ordering directly into the intake workflow.

Michigan Medicaid and Insurance Coverage for Finasteride

Michigan Medicaid (Healthy Michigan Plan) covers finasteride for BPH under the preferred drug list with prior authorization (PA). For AGA, coverage is also available with PA, though approval rates for cosmetic-indication claims are lower than for BPH. Commercial insurers in Michigan vary widely: many cover the 5 mg BPH dose but classify 1 mg AGA treatment as cosmetic and exclude it from formulary.

Prior authorization for Medicaid typically requires: a diagnosis code (L64.x for AGA or N40.x for BPH), documentation of symptom severity (International Prostate Symptom Score for BPH or a clinical description of hair loss pattern for AGA), and confirmation that the prescribing provider is a Michigan Medicaid enrolled provider. PA turnaround time from Michigan DHHS is typically 3 to 5 business days for standard review.

Patients who prefer to bypass insurance can use GoodRx or similar discount cards. Generic finasteride 1 mg, 90-tablet supply, is available for approximately $20 to $35 at most Michigan chain pharmacies [6]. Some mail-order pharmacies ship 90-day supplies for under $15.

Compounding Finasteride at Michigan 503A Pharmacies

Michigan licensed 503A pharmacies may prepare compounded finasteride for individual patients when a prescriber determines that a commercially available product does not meet the patient's specific clinical needs. Common compounding scenarios include topical finasteride formulations (typically 0.1% to 0.25% solution or gel for men who prefer to minimize systemic DHT suppression) and combination formulations pairing finasteride with minoxidil in a single topical vehicle.

Topical finasteride shows promise for reducing systemic DHT exposure. A randomized trial by Caserini et al. (N=24) found that topical finasteride 0.005% once daily reduced scalp DHT by 46% with minimal serum DHT reduction compared to oral finasteride [10]. A larger 2022 study in the Journal of the American Academy of Dermatology (N=323) reported topical finasteride 0.25% was non-inferior to oral 1 mg for hair count at 24 weeks, with a significantly lower incidence of sexual side effects [11].

503A pharmacies operate under Michigan's pharmacy practice act and must comply with USP Chapter 795 standards for non-sterile compounding. Patients and prescribers can verify a Michigan pharmacy's 503A license through the Michigan Board of Pharmacy online registry or the National Association of Boards of Pharmacy's (NABP) database [12]. Compounded finasteride is not FDA-approved, so a signed informed consent documenting the risks of compounded versus commercially manufactured product is best practice.

Transferring a Finasteride Prescription to Michigan

Transferring an existing finasteride prescription to Michigan is straightforward. Under federal law (21 CFR 1306.25), a non-controlled drug prescription may be transferred once between pharmacies in different states. Since finasteride is non-controlled, no DEA-schedule barriers apply.

To transfer, call your new Michigan pharmacy and provide the name and phone number of the originating out-of-state pharmacy. The Michigan pharmacist contacts the original pharmacy directly. If the original prescription has refills remaining, those transfers without requiring a new prescriber visit.

One important caveat: if you are moving to Michigan from a state where your prescription was issued by a telehealth provider not licensed in Michigan, the prescription remains valid for the refills already authorized. Renewing or modifying the prescription, however, requires a Michigan-licensed prescriber. Plan the transition 30 to 60 days before your current supply runs out.

Side Effects and Monitoring for Michigan Patients

Finasteride's side effect profile is well-characterized. The most discussed adverse effects involve sexual function. The original Merck-sponsored phase III trials reported decreased libido (1.8%), erectile dysfunction (1.3%), and decreased ejaculatory volume (0.8%) versus placebo rates of 1.3%, 0.7%, and 0.4%, respectively [4]. Post-marketing reports have described a subset of patients who experience persistent sexual dysfunction after stopping finasteride, termed post-finasteride syndrome (PFS). The FDA added a label update in 2012 to acknowledge persistent sexual side effects [4].

The Post-Finasteride Syndrome Foundation estimates prevalence at less than 2% of long-term users, though systematic epidemiological data remain limited [13]. A 2020 analysis in the Journal of Sexual Medicine (N=11,909) found the absolute risk of persistent erectile dysfunction attributable to finasteride was approximately 0.7% over 5 years of use [14].

Monitoring recommendations during Michigan treatment:

• At 3 months: Symptom check for sexual side effects; PSA recheck for BPH patients.
• At 6 months: PSA for all men over 40. Multiply the result by 2.0 to estimate the PSA equivalent if finasteride were not being taken, per the FDA label correction factor [4].
• At 12 months: Hair count or global photography for AGA patients to confirm treatment response.
• Annually thereafter: PSA, blood pressure (if on concurrent alpha-blockers for BPH), and medication reconciliation.

Breast tenderness or gynecomastia occurs in roughly 0.4% of finasteride users [4]. Any palpable breast mass warrants immediate evaluation regardless of finasteride use, since the drug does not increase breast cancer risk at a statistically significant level in available data.

Finasteride for Women in Michigan: What Prescribers Can and Cannot Do

FDA-approved finasteride indications are limited to men. Finasteride is classified FDA Pregnancy Category X and is absolutely contraindicated in pregnant women or women who may become pregnant due to risk of external genital abnormalities in male fetuses [4]. Female patients must not handle crushed or broken tablets.

Off-label prescribing for women with AGA or hyperandrogenism does occur. Some Michigan dermatologists and endocrinologists prescribe finasteride off-label to post-menopausal women or women using reliable contraception. A 2020 randomized trial by Boersma et al. (N=87) found finasteride 1 mg daily produced a statistically significant reduction in the Ludwig scale score versus placebo in post-menopausal women with AGA over 12 months (P<0.05) [15]. Off-label use requires explicit informed consent and documentation that the patient understands the lack of FDA approval for this population.

Telehealth platforms vary in their willingness to prescribe finasteride off-label for women. Patients in Michigan seeking this pathway should look for platforms that include endocrinologists or dermatologists with documented experience in female AGA rather than general men's health clinics.

Cost Summary for Michigan Patients

| Supply | Form | Estimated Michigan Price | |---|---|---| | 30-day, 1 mg generic oral | AGA | $10 to $25 (GoodRx) | | 90-day, 1 mg generic oral | AGA | $20 to $35 (GoodRx) | | 30-day, 5 mg generic oral | BPH | $15 to $30 (GoodRx) | | 90-day, 5 mg generic oral | BPH | $25 to $50 (GoodRx) | | Topical 0.25% compounded | AGA | $40 to $90 (503A pharmacy, varies) |

Prices updated January 2025. Actual cost varies by pharmacy location and current discount card contract. Always verify price at point of dispensing.